Pluristem Therapeutics Inc (PSTI)

[Mikems]

Stock has been road kill for years, despite patents and ongoing clinical trials. Predictions of it moving to $3 are hallucinatory. No tangible income, several dilutions. Imho, they might as well manufacture bow ties and cotton underwear. Nevertheless there is the faith among some that the company will overcome its bad luck, rise from the grave and steal the spotlight from almost a thousand competitors in the stem cell field, all claiming miracle cures.